Breast-cancer specific comprehensive archive of Patient-Reported Outcome Measures (PROMs) for clinical research and clinical practice in oncology: Results from the PRO4All project
Valsecchi A, Giovanardi F, Malandrini F, Meregaglia M, Servetto A, Bennati C, Pinto C, Di Maio M, Ciani O. Breast-cancer specific comprehensive archive of Patient-Reported Outcome Measures (PROMs) for clinical research and clinical practice in oncology: Results from the PRO4All project. The Breast 2024, 78: 103817. PMID: 39362075, DOI: 10.1016/j.breast.2024.103817.Peer-Reviewed Original ResearchPatient-reported outcome measuresMinimum clinically important differencePatient-reported outcomesOutcome measuresBreast cancerRecall periodInclusion of patient-reported outcomesDelivery of carePatient-centered approachClinically important differenceClinical researchPhysical functionOutcome domainsOutcome classificationImportant differenceSelf-reportOncology clinical trialsQuestionnaireEvaluation of treatmentQuestionnaire descriptionsPublished reviewsClinical practiceOncologyItemsBC patientsSample size in multistakeholder Delphi surveys: at what minimum sample size do replicability of results stabilize?
Manyara A, Purvis A, Ciani O, Collins G, Taylor R. Sample size in multistakeholder Delphi surveys: at what minimum sample size do replicability of results stabilize? Journal Of Clinical Epidemiology 2024, 174: 111485. PMID: 39069013, DOI: 10.1016/j.jclinepi.2024.111485.Peer-Reviewed Original ResearchDelphi surveyCONSORT-SPIParticipant characteristicsReplication of resultsParticipant dataSample sizeCore outcomePsychological interventionsSurvey itemsIntervention trialsDelphi studyBurn careIndividual stakeholder groupsRandom subsampleParticipantsSubgroup analysisStakeholder groupsMultistakeholderSurveyEffect of increasing sample sizeMedian numberItemsSubsampleReduced variabilityCareReporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration
Manyara A, Davies P, Stewart D, Weir C, Young A, Blazeby J, Butcher N, Bujkiewicz S, Chan A, Dawoud D, Offringa M, Ouwens M, Hróbjartsson A, Amstutz A, Bertolaccini L, Bruno V, Devane D, Faria C, Gilbert P, Harris R, Lassere M, Marinelli L, Markham S, Powers J, Rezaei Y, Richert L, Schwendicke F, Tereshchenko L, Thoma A, Turan A, Worrall A, Christensen R, Collins G, Ross J, Taylor R, Ciani O. Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration. The BMJ 2024, 386: e078524. PMID: 38981645, PMCID: PMC11231881, DOI: 10.1136/bmj-2023-078524.Peer-Reviewed Original ResearchConceptsRandomised controlled trial reportsTrial reportsRandomised controlled trialsControlled trial reportsIntervention treatment effectsResearch wasteTrial findingsTreatment effectsControlled trialsTarget outcomesChecklistAdequate informationSurrogate endpointsInterventionCONSORTItemsTrialsImprove transparencyHarmReportsGuidelinesOutcomesEndpointReporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration
Manyara A, Davies P, Stewart D, Weir C, Young A, Blazeby J, Butcher N, Bujkiewicz S, Chan A, Dawoud D, Offringa M, Ouwens M, Hróbjartsson A, Amstutz A, Bertolaccini L, Bruno V, Devane D, Faria C, Gilbert P, Harris R, Lassere M, Marinelli L, Markham S, Powers J, Rezaei Y, Richert L, Schwendicke F, Tereshchenko L, Thoma A, Turan A, Worrall A, Christensen R, Collins G, Ross J, Taylor R, Ciani O. Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration. The BMJ 2024, 386: e078525. PMID: 38981624, PMCID: PMC11231880, DOI: 10.1136/bmj-2023-078525.Peer-Reviewed Original ResearchConceptsTrial protocolRandomised controlled trial protocolTarget outcomesReduce research wasteStandard Protocol ItemsRandomised controlled trialsIntervention effectsProtocol ItemsInterpretation of findingsResearch wasteImprove reportingPrimary outcome(sIntervention trialsControlled trialsChecklistSurrogate endpointsInterventionItemsIncreasing callsTrialsGuidelinesOutcomesLimited informationOutcome(sHarmConsolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI)
Elvidge J, Hawksworth C, Avşar T, Zemplenyi A, Chalkidou A, Petrou S, Petykó Z, Srivastava D, Chandra G, Delaye J, Denniston A, Gomes M, Knies S, Nousios P, Siirtola P, Wang J, Dawoud D, Group T, Arbour S, Asche C, Ashurst C, Balkanyi L, Bennett H, Boros G, Boyce R, Carswell C, Chaiyakunapruk N, Chhatwal J, Ciani O, Collins G, Dawson D, Vanness D, Di Bidino R, Faulding S, Felizzi F, Haig M, Hawkins J, Hiligsmann M, Holst-Kristensen A, Isla J, Koffijberg E, Kostyuk A, Krief N, Lee D, Lee K, Lundin D, Markiewicz-Barreaux K, Mauskopf J, Moons K, Németh B, Petrova G, Pwu R, Rejon-Parrilla J, Rogers G, Sampson C, Springborg A, Steuten L, Sutherland E, Suutala J, Theisen D, Thompson A, van Gemert-Pijnen L, Walker T, Wilson E. Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI). Value In Health 2024, 27: 1196-1205. PMID: 38795956, PMCID: PMC11343728, DOI: 10.1016/j.jval.2024.05.006.Peer-Reviewed Original ResearchConsolidated Health Economic Evaluation Reporting StandardsHealth Economic Evaluation Reporting StandardsReporting ItemsEconomic evaluationHealth interventionsConsensus meetingSurvey rounds 1Likert rating scalePatient perspectivePublished systematic literature reviewRound 2Artificial intelligenceRounds 1Survey roundsHealthcare systemCost-effectiveness conclusionsPotential itemsQualitative commentsDelphi studySystematic literature reviewInterventionRating ScaleItemsParticipantsPatient group